Effects of DMARD Tapering on Treatment Costs and Work Productivity in Rheumatoid Arthritis Patients- an Analysis from the Prospective Randomized Controlled Retro- Study (2016) Hagen M, Figueiredo CP, Cobra JF, Haschka J, Reiser M, Englbrecht M, Hueber A, et al. Conference contribution Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies (2016) Lopez-Isac E, Martin JE, Assassi S, Simeon CP, Carreira P, Ortego-Centeno N, Freire M, et al. Journal article, Report Review: Neutrophils as Invigorated Targets in Rheumatic Diseases (2016) Grayson PC, Schauer C, Herrmann M, Kaplan MJ Journal article, Review article Quantification and impact of secondary osteoarthritis in patients with anti-citrullinated protein antibodies positive rheumatoid arthritis (2016) Figueiredo CP, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, Hueber A, et al. Journal article Inhibition of Osteoarthritis by Adipose-Derived Stromal Cells Overexpressing Fra-1 in Mice (2016) Schwabe K, Garcia M, Ubieta K, Hannemann N, Herbort B, Luther J, Noel D, et al. Journal article A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM (2016) Zhuang H, Han S, Li Y, Kienhöfer D, Lee P, Shumyak S, Meyerholz R, et al. Journal article Bone Microstructure Assessed By Hrpqct in Subjects with Hyperuricemia without Arthritis (2015) Kocijan R, Nia A, Muschitz C, Simon D, Geiger C, Haschka J, Kleyer A, et al. Conference contribution Prediction of Disease Relapses By Multi-Biomarker Disease Test Activity in Rheumatoid Arthritis Patients Tapering DMARD Treatment (2015) Rech J, Hueber A, Englbrecht M, Finzel S, Haschka J, Manger B, Kleyer A, et al. Conference contribution Cardiomyopathy in murine models of systemic sclerosis (2015) Venalis P, Kumanovics G, Schulze-Koops H, Distler A, Dees C, Zerr P, Palumbo-Zerr K, et al. Journal article Combined Inhibition of Tumor Necrosis Factor ? and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody (2015) Fischer JAA, Hueber A, Wilson S, Galm M, Baum W, Kitson C, Auer J, et al. Journal article